InvestorsHub on MSN
Terns Pharma stock jumps on report of potential $6B takeover by Merck
Terns Pharmaceuticals (NASDAQ:TERN) shares surged in premarket trading after a report indicated that Merck & Company ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Merck & Co., Inc. (NYSE:MRK) is one of the 10 Most Profitable S&P 500 Stocks to Buy Now. On March 20, 2026, Citi raised the ...
Shares of Merck & Co. Inc. MRK slipped 1.18% to $114.50 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.36% to 6,624.70 ...
Merck (NYSE: MRK) has taken its shareholders on a wild ride of late -- from last March's record high of more than $130 to this May's low near $76 back to its current price of just a little more ...
MRK, is presenting new long term data on its GARDASIL 9 and GARDASIL HPV vaccines at a major international HPV congress. The ...
Stocktwits on MSN
SLS vs. TERN: Which pharma stock has more upside as Merck eyes $6B cancer bet ahead of Keytruda patent cliff
SLS and TERN are advancing leukemia therapies, with TERN-701 targeting CML and GPS positioned as a Phase 3 maintenance ...
Zacks Investment Research on MSN
Merck (MRK) exceeds market returns: Some facts to consider
In the latest close session, Merck (MRK) was up +1.31% at $115.68. The stock's change was more than the S&P 500's daily gain of 1.15%. At the same time, the Dow added 1.38%, and the tech-heavy Nasdaq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results